- $2.25m
- -$3.19m
- $0.07m
Brief: Silo Pharma - Commenced Development Of Novel Formulation As Targeted Prophylactic Treatment, Designated As Spc-15, Intended For Stress, Anxiety & PTSD
Brief: Silo Pharma Announces Filing Of Patent For Treatment Of Fibromyalgia
U.S. STOCKS ON THE MOVE-Jack Henry, Coty, Netflix
U.S. STOCKS ON THE MOVE-Boeing, Alcoa, Canadian Pacific
Silo Pharma rises on promising results from pain disorder drug study
Brief: Silo Pharma Announces Positive Results From IND-Enabling Study Of SP-26
Silo Pharma rises on filing of patent for Alzheimer's treatment
Brief: Silo Pharma Announces Filing Of Patent For Treatment Of Alzheimer's
Silo Pharma jumps on U.S. patent for anxiety drug
Brief: Silo Pharma Announces Expansion Of Intellectual Property Portfolio
Brief: Silo Pharma Announces Stock Repurchase Program
Brief: Silo Pharma Advances Clinical Study Analyzing Effects Of Psilocybin On Inflammation
U.S. STOCKS ON THE MOVE-Dynagas, Disc Medicine, Walmart
U.S. STOCKS ON THE MOVE-Silo Pharma, Meta Platforms, Campbell Soup
Brief: Silo Pharma Announces Positive Study Results Of Spu- 21 For Arthritis
Silo Pharma soars on positive data in arthritis drug study
Brief: Silo Pharma Initiates Study Of Novel Joint Homing Peptide In Human Tissue
U.S. STOCKS ON THE MOVE-Lam Research, Cyngn, Par Pacific
Silo Pharma rises on pre-clinical data on novel Alzheimer's drug